AUBREY STORELLI: Open Payments
NPI 1689322018 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,701 in 130 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $2,826 · 2025 $2,701
Food & beverage: $2,701
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $633 |
| Amgen Inc. | 12 | $355 |
| Mallinckrodt Hospital Products Inc. | 8 | $213 |
| Novartis Pharmaceuticals Corporation | 12 | $209 |
| Janssen Biotech, Inc. | 11 | $188 |
| PFIZER INC. | 12 | $161 |
| AstraZeneca Pharmaceuticals LP | 7 | $149 |
| E.R. Squibb & Sons, L.L.C. | 6 | $146 |
| GlaxoSmithKline, LLC. | 6 | $115 |
| UCB, Inc. | 6 | $99 |
Products named: RINVOQ, KRYSTEXXA, ACTHAR, COSENTYX, TREMFYA, XELJANZ, SAPHNELO, ORENCIA.
Industry payments across TX — which companies pay providers there.
